Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06984276Recruiting
Randomised, double-blind trial of bupivacaine hydrochloride 0.75% injection and Lidocaine Hydrochloride Injection, without epinephrine in postoperative pain (3 arms), sponsored by Cairo University. Primary endpoint: Total dose of intraoperative fentanyl. Started Sep 2024; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06984276.